Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14.1Revenue (TTM) $M9.2Net Margin (%)4.0Altman Z-Score16.2
Enterprise Value $M9.8EPS (TTM) $-0.0Operating Margin %86.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)86.8Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio21.3Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %--Current Ratio21.3Lower Leverage y-yY
Price/Free Cash Flow3.0y-y EBITDA Growth Rate %-4.2ROA % (ttm)2.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)2.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.2ROIC % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ENZN is held by these investors:



ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ICAHN CARL C10% Owner 2016-11-28Buy694,023$0.41-21.95view
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-81.4view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-95.14view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-95.14view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-95.35view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-95.3view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-95.28view
Young Richard ADirector 2012-03-15Sell2,000$6.92-95.38view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-95.21view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-95.47view

Quarterly/Annual Reports about ENZN:

News about ENZN:

Articles On GuruFocus.com
Carl Icahn Discloses 20 Million Share Stake in Xerox Spinoff Conduent Jan 10 2017 
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016 
Top Micro-Cap Picks From the Gurus Jun 23 2015 
Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
GuruFocus Real Time Picks of the Week Jan 10 2014 
Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
First Pacific Advisors’ Top New Buys Aug 08 2012 
Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK